North Korea's Missile Tech to Iran: Will Congress Redirect Ukraine Aid to Fuel LMT and RTX's Middle East Missile Surge?
Newly revealed military ties between Iran and North Korea— including transfers of advanced offensive missile systems and defensive tunnel construction technology— have escalated Middle East tensions just as U.S. lawmakers debate redirecting Ukraine aid. This CRINK (China-Russia-Iran-North Korea) axis bolstering threatens U.S. allies like Israel and Saudi Arabia, amplifying calls in Congress to pivot billions from Ukraine's arsenal replenishment toward immediate Middle East missile defense needs.
The signal underscores a pivotal investment crossroads for defense giants Lockheed Martin (LMT) and RTX (RTX), whose missile programs stand ready to absorb redirected funds. With LMT's backlog at a record $176 billion and RTX's at $218 billion as of late 2025, any Ukraine-to-Middle-East aid shift could ignite multi-year revenue ramps.
NK-Iran Escalation: A Direct Threat to U.S. Missile Superiority
Iran's acquisition of North Korean ballistic missile tech—capable of evading current defenses—and underground tunnel expertise mirrors tactics used against Ukraine, per recent intelligence. This isn't abstract: North Korea's KN-23/24 missiles, now potentially in Iranian hands, feature hypersonic glides and solid-fuel propulsion, challenging PAC-3 MSE (LMT) and Patriot GEM-T (RTX) interceptors.
Congressional hawks, citing depleted U.S. stockpiles from Ukraine aid ($61 billion committed since 2022), argue redirection is essential. A House bill proposes shifting $10-20 billion annually to Israel/Saudi FMS (Foreign Military Sales), directly funding LMT's 120 PAC-3 deliveries in 2025 and RTX's NASAMS/GEM-T exports. Without it, Middle East vulnerabilities mirror Ukraine's early war losses.
LMT and RTX: Backlogs Primed for Aid Pivot
Both primes are capacity-constrained but investing aggressively. LMT ended FY2025 with $75.1 billion revenue (up 5.7% YoY), $5.0 billion net income, and $6.9 billion FCF, fueling $5 billion 2026 capex for F-35, PAC-3, and THAAD ramps. Earnings highlights: Seven-year PAC-3 framework and THAAD agreements target commercial-scale production.
RTX mirrored: FY2025 sales implied ~$88.6 billion (11% organic growth), backlog up to $218 billion (book-to-bill 1.56). Raytheon segment eyes mid-high single-digit growth, with $8.25-8.75 billion FCF guidance for 2026.
| Metric | LMT FY2025 | RTX FY2025 (Implied) | YoY Change |
|---|---|---|---|
| Revenue | $75.1B | $88.6B | +5.7% / +11% |
| Net Income | $5.0B | N/A | Stable |
| FCF | $6.9B | $8.5B mid | +30% / Strong |
| Backlog | $176B | $218B | +10% / +23% |
| 2026 Sales Guide | $77-80B (+5%) | $92-93B (+5-6%) | Growth intact |
37% of LMT's backlog converts in 12 months; RTX's defense slice ($107B) includes Middle East FMS. SEC filings flag Middle East risks but affirm FMS resilience—LMT notes 26% international sales, RTX monitors Israel ops amid Houthi threats.
Recent prices reflect caution: LMT traded ~$617 (April 2026), up 2.2% daily but -8% from March peaks amid budget debates. RTX similar, with YTD returns muted despite backlogs.
Congressional Momentum: From Debate to Dollars?
Ukraine aid fatigue grows—$175B total U.S. spend, with 40% munitions now to Middle East proxies. NK-Iran news tips scales: Senate hearings cite "asymmetric threats" needing $15B redirection for interceptors. LMT's Q4 2025 call: "Record PAC-3 deliveries"; RTX: Defense book-to-bill 1.63.
Geopolitics align: SEC 10-Ks warn of Ukraine/Middle East conflicts boosting demand but risking supply snarls. Yet, both firms report mitigated tariff impacts and ramp readiness.
Bullish Case: Defense Spending Floor at $900B+
Buy LMT/RTX: Escalation + aid pivot = backlog conversion acceleration. LMT's P/E TTM ~28x, RTX ~25x fwd, reasonable vs. 10%+ EPS growth guides. XLE (Energy ETF) hedges oil spikes from Gulf risks, up on Iran tensions.
LMT ROE TTM 100%+ (leverage-aided), RTX debt/equity manageable at ~0.7x. FCF yields support 2-3% dividends + buybacks.
| Stock | Price (Apr 2026) | 1M Return | YTD Return | EV/EBITDA TTM |
|---|---|---|---|---|
| LMT | $618 | -2% | +15% | 18x |
| RTX | N/A (proxy) | Stable | +12% | 16x |
| XLE | N/A | +3% | +8% | N/A |
Neutral on XLE—oil at $80/bbl caps upside unless Strait closure.
Watch These Catalysts
- House Vote (Q2 2026): $10B redirection bill passage triggers 5-10% stock pops.
- Saudi FMS Deal: $5B PAC-3/THAAD award, backlog +2-3%.
- Q1 Earnings: Capacity updates; misses on Ukraine drawdown risk shares.
Iran-NK ties make redirection inevitable—position for the surge.